Who are the top 5 healthcare stocks?

As of 27th July 2026, the top 5 healthcare stocks as per market cap include: Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Disclaimer: The above US healthcare stocks list is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

What is the outlook for US healthcare stocks?

The 2026 outlook is shaped by continued strong demand for GLP-1 metabolic disease treatments, ongoing patent cliff pressures across several major drug franchises, and health insurers working to stabilise medical cost trends through pricing and operational discipline. Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

Are US healthcare stocks risky for Indian investors?

Indian investors face currency risk from rupee-dollar fluctuations, sector-specific risks such as patent cliff exposure and drug pricing policy changes, and an additional compliance layer under the Liberalised Remittance Scheme.

How can I compare US healthcare stocks on Tickertape?

Investors can use the Tickertape US Stock Screener to filter healthcare companies by financial metrics, and use the peer comparison section on individual stock pages to compare fundamentals such as pipeline strength, margins and valuation.

Can beginners invest in US healthcare stocks?

Beginners can invest in US healthcare stocks, but the sector can be sensitive to clinical trial outcomes, patent expiry timelines and healthcare policy developments. Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

How to invest in US healthcare stocks from India?

Create an account: Open a US investing account on Tickertape. Explore healthcare stocks: Compare companies across pharmaceuticals, health insurance and medical technology. Complete KYC: Verify your identity digitally or submit the required documents. Link a bank account: Connect an eligible bank account for LRS remittances. Add funds: Transfer money to your US investing account. Place an order: Select a healthcare stock and invest, including fractionally where available.

What are the advantages of investing in US healthcare stocks?

US healthcare stocks provide exposure to defensive cash flow characteristics, exposure to high-growth areas such as GLP-1 treatments, and access to companies with strong pipelines and diversified revenue bases. They also offer consistent dividend payments from several established players. Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

What is the difference between individual US healthcare stocks and healthcare-focused ETFs?

Individual healthcare stocks provide exposure to a specific company's pipeline, therapeutic focus and patent timeline, while healthcare ETFs invest in a basket of companies across pharmaceuticals, insurance and medical technology.

What metrics are commonly used to evaluate US healthcare stocks?

Common metrics include revenue growth, pipeline strength and late-stage trial progress, patent expiry timelines, medical care ratio for insurers, price-to-earnings ratio and dividend yield. Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

Do US healthcare stocks pay dividends?

Several large-cap pharmaceutical companies are recognised as consistent dividend payers, supported by strong cash generation from established drug portfolios, while health insurers and growth-focused biotechnology companies may prioritise reinvestment over dividends. Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

Healthcare Stocks: Leading Healthcare Companies in the US in 2026

Q: What are US healthcare stocks?

US healthcare stocks are shares of US-listed companies involved in pharmaceuticals, biotechnology, health insurance and medical technology. This includes diversified pharmaceutical majors as well as health insurers and companies focused on specific therapeutic areas.

Eli Lilly became the world's most valuable healthcare company in 2025, crossing a $1 trillion market capitalisation on the back of surging demand for its obesity and diabetes medicines, while established players such as Johnson & Johnson and AbbVie have delivered strong operational performance despite patent expiry pressures. In this article, we will be covering all the US healthcare stocks that might benefit from this environment, along with an overview of the top pharmaceutical and health insurance companies.

List of US Healthcare Stocks in 2026

US Healthcare Stocks

Explore US healthcare stocks across pharmaceuticals, biotechnology, medical devices, healthcare services and diagnostics. Analyse companies using live share price, market cap, returns, valuation, profitability and other key financial metrics.

Created by

@8260032 8260032

Showing 1 - 20 of 1077 results

last updated at 8:30 AM IST

	NameUS Stocks (1077)↓	↓Sub-SectorSub-Sector↓	↓Market CapMarket Cap↓	↓Close PriceClose Price↓	↓PE Ratio (TTM)PE Ratio (TTM)↓	↓1M Return1M Return↓	↓1D Return1D Return↓	↓Return on EquityReturn on Equity↓	↓PB RatioPB Ratio↓
1.	Eli Lilly and Company LLY	Drug Manufacturers - GeneralDrug Manufacturers - General	11,32,691.9811,32,691.98	1,273.461,273.46	43.0943.09	10.6410.64	-2.51-2.51	102.29102.29	30.2830.28
2.	Johnson & Johnson JNJ	Drug Manufacturers - GeneralDrug Manufacturers - General	6,21,223.616,21,223.61	263.81263.81	39.1239.12	-1.99-1.99	-1.40-1.40	25.7425.74	7.637.63
3.	AbbVie Inc ABBV	Drug Manufacturers - GeneralDrug Manufacturers - General	5,03,275.005,03,275.00	285.19285.19	80.4580.45	7.597.59	0.150.15	62.2562.25	50.4650.46
4.	UnitedHealth Group Incorporated UNH	Healthcare PlansHealthcare Plans	3,74,297.033,74,297.03	418.09418.09	26.8226.82	12.6012.60	-1.62-1.62	15.7715.77	3.403.40
5.	Merck & Company Inc MRK	Drug Manufacturers - GeneralDrug Manufacturers - General	3,69,779.703,69,779.70	145.27145.27	118.95118.95	-1.90-1.90	-1.34-1.34	6.966.96	8.718.71
6.	Novartis AG ADR NVS	Drug Manufacturers - GeneralDrug Manufacturers - General	2,92,577.022,92,577.02	151.12151.12	23.2523.25	5.895.89	-3.31-3.31	30.3530.35	6.536.53
7.	AstraZeneca PLC AZN	Drug Manufacturers - GeneralDrug Manufacturers - General	2,61,250.072,61,250.07	171.49171.49	25.1825.18	5.005.00	-0.62-0.62	21.9721.97	5.195.19
8.	Thermo Fisher Scientific Inc TMO	Diagnostics & ResearchDiagnostics & Research	2,56,612.022,56,612.02	673.82673.82	36.6036.60	1.281.28	-0.41-0.41	13.5213.52	4.674.67
9.	Amgen Inc AMGN	Drug Manufacturers - GeneralDrug Manufacturers - General	2,36,980.632,36,980.63	439.26439.26	27.2327.23	8.178.17	-1.81-1.81	91.4791.47	18.7818.78
10.	Gilead Sciences Inc GILD	Drug Manufacturers - GeneralDrug Manufacturers - General	1,90,419.931,90,419.93	156.04156.04	--	3.093.09	-0.71-0.71	-20.68-20.68	16.0016.00
11.	Abbott Laboratories ABT	Medical DevicesMedical Devices	1,73,920.831,73,920.83	102.51102.51	37.3637.36	-0.95-0.95	1.161.16	10.5810.58	3.503.50
12.	Novo Nordisk A/S NVO	Drug Manufacturers - GeneralDrug Manufacturers - General	1,72,376.101,72,376.10	39.0539.05	9.559.55	2.312.31	-1.00-1.00	59.8259.82	4.974.97
13.	Pfizer Inc PFE	Drug Manufacturers - GeneralDrug Manufacturers - General	1,70,135.261,70,135.26	30.0330.03	39.2839.28	6.566.56	-1.33-1.33	5.015.01	1.891.89
14.	Danaher Corporation DHR	Diagnostics & ResearchDiagnostics & Research	1,64,400.321,64,400.32	230.50230.50	38.7238.72	4.044.04	0.290.29	7.617.61	2.962.96
15.	Intuitive Surgical Inc ISRG	Medical Instruments & SuppliesMedical Instruments & Supplies	1,51,245.391,51,245.39	452.29452.29	51.7751.77	13.5613.56	1.881.88	17.9317.93	7.827.82
16.	Vertex Pharmaceuticals Inc VRTX	BiotechnologyBiotechnology	1,32,945.331,32,945.33	523.93523.93	30.3730.37	1.471.47	-2.10-2.10	23.5423.54	6.466.46
17.	Bristol-Myers Squibb Company BMY	Drug Manufacturers - GeneralDrug Manufacturers - General	1,24,850.721,24,850.72	61.4861.48	13.4613.46	0.540.54	-2.40-2.40	46.6046.60	5.605.60
18.	CVS Health Corp CVS	Healthcare PlansHealthcare Plans	1,19,519.781,19,519.78	93.4793.47	24.5924.59	8.868.86	-1.04-1.04	6.216.21	1.451.45
19.	Medtronic PLC MDT	Medical DevicesMedical Devices	1,18,998.201,18,998.20	95.4195.41	22.8622.86	6.846.84	-1.22-1.22	10.6510.65	2.272.27
20.	McKesson Corporation MCK	Medical DistributionMedical Distribution	1,18,397.511,18,397.51	1,000.771,000.77	27.6127.61	13.6613.66	-1.16-1.16	--	5.045.04

Edit Filters

Analyse US healthcare stocks further

Visit 'US Healthcare Stocks' Screener

Disclaimer: Please note that the above table is for informational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.

Overviews of Top US Healthcare Stocks

Eli Lilly and Company

Eli Lilly is a global pharmaceutical company with products across diabetes, obesity, cancer, immunology and neuroscience. It is best known for its GLP-1 medicines and is expanding manufacturing capacity to meet rising demand. The company also uses acquisitions and licensing deals to strengthen its drug pipeline.

Johnson & Johnson

Johnson & Johnson operates across medicines and medical technology. After separating its consumer health business, the company now focuses on pharmaceuticals, surgical products, orthopaedics and other medical technologies. This gives it exposure to several areas of the healthcare sector.

AbbVie Inc

AbbVie is a biopharmaceutical company focused on immunology, cancer, neuroscience, eye care and medical aesthetics. It has expanded beyond Humira through newer medicines such as Skyrizi and Rinvoq and continues to build its pipeline through research and acquisitions.

UnitedHealth Group Incorporated

UnitedHealth Group operates across health insurance and healthcare services. UnitedHealthcare provides health benefit plans, while Optum offers care delivery, pharmacy services, data analytics and technology solutions. This gives the company exposure to several parts of the US healthcare system.

Merck & Company Inc

Merck is a global pharmaceutical company that develops medicines and vaccines across cancer, infectious diseases, cardiometabolic conditions and animal health. It is widely known for Keytruda and also maintains a broader portfolio of vaccines and medicines under development.

What are US Healthcare Stocks?

US healthcare stocks are shares of companies involved in pharmaceuticals, biotechnology, health insurance, medical technology and healthcare services. The sector includes large diversified pharmaceutical majors, health insurers and companies focused on specific therapeutic areas or healthcare delivery models.

How to Evaluate and Invest in US Healthcare Sector Stocks?

Here's how to invest in the US healthcare stock market from India, step by step:

Log in or Create an Account: Visit Tickertape US Stocks and log in to your account. Create an account if you have not registered yet and complete the US investing account-opening process.
Search for Healthcare Stocks: Use the Tickertape US Stock Screener and select 'Healthcare' under the sector filter.
Analyse the Stocks: Each stock page provides information such as the live market price, 52-week range, financial performance, peer comparison and recent news.
Add Money to Your US Wallet: Connect an eligible bank account and transfer money to your US Wallet under the Liberalised Remittance Scheme.
Place Your Order: Select the healthcare stock you want to invest in and click on 'Buy' to place the order through Tickertape.

Taxation of US Healthcare Stocks for Indian Investors

The tax treatment of US healthcare stocks generally depends on the holding period, the investor's applicable income-tax rate and US withholding rules on dividend income.

Income	Holding Period / Condition	Tax Rate in the US	Tax Rate in India
Long-Term Capital Gains (LTCG)	Held for > 24 months	0% (Taxed only in India under DTAA)	12.5% (+ applicable surcharge & cess)
Short-Term Capital Gains (STCG)	Held for < 24 months	0% (Taxed only in India under DTAA)	Taxed as per your applicable income slab rate

Benefits of Investing in US Healthcare Stocks

Exposure to GLP-1 Growth

Demand for diabetes and obesity medicines helped a leading pharmaceutical company cross a $1 tn market capitalisation in November 2025. Its metabolic health products generated more than $10 bn in quarterly revenue.

Diversified Healthcare Revenue

Companies operating across pharmaceuticals and medical technology can reduce dependence on one product category. A major diversified healthcare company generated $94.2 bn in 2025 sales and approximately $19.7 bn in free cash flow.

New Product Growth

Successful drug launches can help pharmaceutical companies offset revenue lost after patent expiry. Two newer immunology treatments generated combined revenue of $25.87 bn in 2025.

Integrated Healthcare Exposure

Managed-care companies combine insurance, pharmacy benefits, healthcare delivery and analytics. One major insurer served 49.8 mn consumers, while its healthcare services division generated $270.6 bn in 2025 revenue.

Dividend Income Potential

Established healthcare companies may distribute part of their cash flow through dividends. Large pharmaceutical companies continued raising or maintaining quarterly payouts in 2025 and 2026.

Download Now

Risks of Investing in Healthcare Stocks

Patent Expiry Risk

More than $200 bn in branded drug revenue could face generic or biosimilar competition between 2026 and 2030.

Drug Pricing Pressure

Medicare-negotiated prices for the first 10 selected prescription drugs took effect on 1 January 2026. Wider price negotiations could reduce revenue and margins for affected pharmaceutical companies.

Rising Medical Costs

US health plans expect commercial medical costs to rise by 9% in 2027, following a revised 9% estimate for 2026.

Clinical Trial Failure

Only around 33% of medicines entering Phase 2 progress to Phase 3, while 25% to 30% of Phase 3 candidates advance further.

Therapeutic Competition

High-growth markets such as obesity treatment continue to attract new injectable and oral medicines.

Key Factors That Influence US Healthcare Stocks' Performance

Drug Development Outcomes

Clinical trial results, regulatory approvals and commercial launches can significantly affect pharmaceutical revenue expectations.

Patent Expiry Exposure

The timing of patent expirations influences future revenue visibility. Companies with concentrated dependence on a few blockbuster drugs face greater pressure when generic or biosimilar competition begins.

Medical Cost Trends

Health insurer profitability depends heavily on the relationship between premiums collected and medical claims paid.

Healthcare Policy Changes

Medicare drug negotiations, reimbursement rules, insurance regulations and changes to public healthcare programmes can alter pricing power and earnings expectations.

Membership Mix

Managed-care performance depends on enrolment growth and the proportion of members across commercial, Medicare and Medicaid plans.

Key Growth Drivers for Healthcare Stocks

GLP-1 Treatment Expansion

The global GLP-1 market was valued at $66.4 bn in 2025 and is projected to reach $82 bn in 2026, supported by obesity demand, broader indications and oral formulations.

Patent Replacement Pipelines

Between $200 bn and $400 bn of branded drug revenue faces loss of exclusivity from 2025 to 2030, increasing investment in new medicines, licensing agreements and biotechnology acquisitions.

AI Adoption in Healthcare

Insurers and healthcare providers are expanding practical AI applications across claims processing, fraud detection, clinical workflows and administrative tasks.

Oncology and Vaccine Innovation

Cancer medicines remain a major pharmaceutical growth area, while vaccines provide portfolio diversification.

Medical Technology Demand

The global medical devices market was valued at $572.31 bn in 2025 and is projected to reach $604.99 bn in 2026.

How to Track the Best US Healthcare Stocks from India on Tickertape?

You can track the top US healthcare stocks and ETFs from India on Tickertape's US Stocks & ETFs platform.

Log in: Visit Tickertape and sign in to your account.
Search healthcare stocks: Look up companies involved in pharmaceuticals, health insurance and medical technology, or explore healthcare-focused ETFs.
Use the screener: Filter US stocks and ETFs by healthcare or related sectors.
Compare metrics: Review live prices, market capitalisation, returns, valuation ratios, profitability, financial health, risk indicators and ETF holdings.
Create a watchlist: Add selected healthcare stocks and ETFs to monitor their prices, financial performance and company developments over time.

Conclusion

US healthcare stocks provide exposure to pharmaceuticals, health insurance, medical technology and other healthcare services. Their performance depends on drug development outcomes, patent expiry timelines, medical cost trends, membership growth and healthcare policy changes. Risks such as patent cliffs, pricing pressure, rising treatment costs and regulatory setbacks can affect companies differently across the sector. Investors can use the Tickertape US Stock Screener to compare healthcare stocks using 60+ unique filters and custom filters across valuation, profitability, growth, financial health and other key metrics.

Popular US Stock Collections

Popular Indian Mutual Fund Collections

Frequently Asked Questions About Healthcare Stocks

What are US healthcare stocks?
US healthcare stocks are shares of US-listed companies involved in pharmaceuticals, biotechnology, health insurance and medical technology. This includes diversified pharmaceutical majors as well as health insurers and companies focused on specific therapeutic areas.
Who are the top 5 healthcare stocks?
As of 27th July 2026, the top 5 healthcare stocks as per market cap include:
1. Eli Lilly and Company
2. Johnson & Johnson
3. AbbVie Inc
4. UnitedHealth Group Incorporated
5. Merck & Company Inc
Disclaimer: The above US healthcare stocks list is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.
What is the outlook for US healthcare stocks?
The 2026 outlook is shaped by continued strong demand for GLP-1 metabolic disease treatments, ongoing patent cliff pressures across several major drug franchises, and health insurers working to stabilise medical cost trends through pricing and operational discipline.

Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.
Are US healthcare stocks risky for Indian investors?
Indian investors face currency risk from rupee-dollar fluctuations, sector-specific risks such as patent cliff exposure and drug pricing policy changes, and an additional compliance layer under the Liberalised Remittance Scheme.
How can I compare US healthcare stocks on Tickertape?
Investors can use the Tickertape US Stock Screener to filter healthcare companies by financial metrics, and use the peer comparison section on individual stock pages to compare fundamentals such as pipeline strength, margins and valuation.
Can beginners invest in US healthcare stocks?
Beginners can invest in US healthcare stocks, but the sector can be sensitive to clinical trial outcomes, patent expiry timelines and healthcare policy developments.

Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.
How to invest in US healthcare stocks from India?
1. Create an account: Open a US investing account on Tickertape.
2. Explore healthcare stocks: Compare companies across pharmaceuticals, health insurance and medical technology.
3. Complete KYC: Verify your identity digitally or submit the required documents.
4. Link a bank account: Connect an eligible bank account for LRS remittances.
5. Add funds: Transfer money to your US investing account.
6. Place an order: Select a healthcare stock and invest, including fractionally where available.
What are the advantages of investing in US healthcare stocks?
US healthcare stocks provide exposure to defensive cash flow characteristics, exposure to high-growth areas such as GLP-1 treatments, and access to companies with strong pipelines and diversified revenue bases. They also offer consistent dividend payments from several established players.

Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.
What is the difference between individual US healthcare stocks and healthcare-focused ETFs?
Individual healthcare stocks provide exposure to a specific company's pipeline, therapeutic focus and patent timeline, while healthcare ETFs invest in a basket of companies across pharmaceuticals, insurance and medical technology.
What metrics are commonly used to evaluate US healthcare stocks?
Common metrics include revenue growth, pipeline strength and late-stage trial progress, patent expiry timelines, medical care ratio for insurers, price-to-earnings ratio and dividend yield.

Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.
Do US healthcare stocks pay dividends?
Several large-cap pharmaceutical companies are recognised as consistent dividend payers, supported by strong cash generation from established drug portfolios, while health insurers and growth-focused biotechnology companies may prioritise reinvestment over dividends.

Disclaimer: This information is for educational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before investing.

Disclaimer: This article is for informational purposes only. The content of the article, including securities/investment products mentioned, if any, should not in any manner be construed as investment advice, recommendation, offer, or solicitation to buy/hold/sell any securities/investment products. The securities quoted, if any, are for illustration only and are not recommendatory. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered financial advisor before investing.